Coexisting of COX7A2L–ALK, LINC01210–ALK, ATP13A4–ALK and Acquired SLCO2A1–ALK in a Lung Adenocarcinoma with Rearrangements Loss During the Treatment of Crizotinib and Ceritinib: A Case Report

Cai C, Long Y, Li Y, Huang M

OncoTargets and Therapy 2020, 13:8313-8316

Published Date: 20 August 2020